Global and United States Personalized Medicine Market Size, Status and Forecast 2021-2027

Global and United States Personalized Medicine Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Personalized Medicine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Personalized Medicine Diagnostics
1.2.3 Personalized Medical Care
1.2.4 Personalized Medicine Therapeutics
1.2.5 Personalized Nutrition and Wellness
1.3 Market by Application
1.3.1 Global Personalized Medicine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Oncology
1.3.3 Central Nervous System (CNS)
1.3.4 Immunology
1.3.5 Respiratory
1.3.6 Other Applications
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Personalized Medicine Market Perspective (2016-2027)
2.2 Personalized Medicine Growth Trends by Regions
2.2.1 Personalized Medicine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Personalized Medicine Historic Market Share by Regions (2016-2021)
2.2.3 Personalized Medicine Forecasted Market Size by Regions (2022-2027)
2.3 Personalized Medicine Industry Dynamic
2.3.1 Personalized Medicine Market Trends
2.3.2 Personalized Medicine Market Drivers
2.3.3 Personalized Medicine Market Challenges
2.3.4 Personalized Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Personalized Medicine Players by Revenue
3.1.1 Global Top Personalized Medicine Players by Revenue (2016-2021)
3.1.2 Global Personalized Medicine Revenue Market Share by Players (2016-2021)
3.2 Global Personalized Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Personalized Medicine Revenue
3.4 Global Personalized Medicine Market Concentration Ratio
3.4.1 Global Personalized Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Personalized Medicine Revenue in 2020
3.5 Personalized Medicine Key Players Head office and Area Served
3.6 Key Players Personalized Medicine Product Solution and Service
3.7 Date of Enter into Personalized Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Personalized Medicine Breakdown Data by Type
4.1 Global Personalized Medicine Historic Market Size by Type (2016-2021)
4.2 Global Personalized Medicine Forecasted Market Size by Type (2022-2027)
5 Personalized Medicine Breakdown Data by Application
5.1 Global Personalized Medicine Historic Market Size by Application (2016-2021)
5.2 Global Personalized Medicine Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Personalized Medicine Market Size (2016-2027)
6.2 North America Personalized Medicine Market Size by Type
6.2.1 North America Personalized Medicine Market Size by Type (2016-2021)
6.2.2 North America Personalized Medicine Market Size by Type (2022-2027)
6.2.3 North America Personalized Medicine Market Size by Type (2016-2027)
6.3 North America Personalized Medicine Market Size by Application
6.3.1 North America Personalized Medicine Market Size by Application (2016-2021)
6.3.2 North America Personalized Medicine Market Size by Application (2022-2027)
6.3.3 North America Personalized Medicine Market Size by Application (2016-2027)
6.4 North America Personalized Medicine Market Size by Country
6.4.1 North America Personalized Medicine Market Size by Country (2016-2021)
6.4.2 North America Personalized Medicine Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Personalized Medicine Market Size (2016-2027)
7.2 Europe Personalized Medicine Market Size by Type
7.2.1 Europe Personalized Medicine Market Size by Type (2016-2021)
7.2.2 Europe Personalized Medicine Market Size by Type (2022-2027)
7.2.3 Europe Personalized Medicine Market Size by Type (2016-2027)
7.3 Europe Personalized Medicine Market Size by Application
7.3.1 Europe Personalized Medicine Market Size by Application (2016-2021)
7.3.2 Europe Personalized Medicine Market Size by Application (2022-2027)
7.3.3 Europe Personalized Medicine Market Size by Application (2016-2027)
7.4 Europe Personalized Medicine Market Size by Country
7.4.1 Europe Personalized Medicine Market Size by Country (2016-2021)
7.4.2 Europe Personalized Medicine Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Personalized Medicine Market Size (2016-2027)
8.2 Asia-Pacific Personalized Medicine Market Size by Type
8.2.1 Asia-Pacific Personalized Medicine Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Personalized Medicine Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Personalized Medicine Market Size by Type (2016-2027)
8.3 Asia-Pacific Personalized Medicine Market Size by Application
8.3.1 Asia-Pacific Personalized Medicine Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Personalized Medicine Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Personalized Medicine Market Size by Application (2016-2027)
8.4 Asia-Pacific Personalized Medicine Market Size by Region
8.4.1 Asia-Pacific Personalized Medicine Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Personalized Medicine Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Personalized Medicine Market Size (2016-2027)
9.2 Latin America Personalized Medicine Market Size by Type
9.2.1 Latin America Personalized Medicine Market Size by Type (2016-2021)
9.2.2 Latin America Personalized Medicine Market Size by Type (2022-2027)
9.2.3 Latin America Personalized Medicine Market Size by Type (2016-2027)
9.3 Latin America Personalized Medicine Market Size by Application
9.3.1 Latin America Personalized Medicine Market Size by Application (2016-2021)
9.3.2 Latin America Personalized Medicine Market Size by Application (2022-2027)
9.3.3 Latin America Personalized Medicine Market Size by Application (2016-2027)
9.4 Latin America Personalized Medicine Market Size by Country
9.4.1 Latin America Personalized Medicine Market Size by Country (2016-2021)
9.4.2 Latin America Personalized Medicine Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Personalized Medicine Market Size (2016-2027)
10.2 Middle East & Africa Personalized Medicine Market Size by Type
10.2.1 Middle East & Africa Personalized Medicine Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Personalized Medicine Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Personalized Medicine Market Size by Type (2016-2027)
10.3 Middle East & Africa Personalized Medicine Market Size by Application
10.3.1 Middle East & Africa Personalized Medicine Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Personalized Medicine Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Personalized Medicine Market Size by Application (2016-2027)
10.4 Middle East & Africa Personalized Medicine Market Size by Country
10.4.1 Middle East & Africa Personalized Medicine Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Personalized Medicine Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Personalized Medicine Introduction
11.1.4 Abbott Laboratories Revenue in Personalized Medicine Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Details
11.2.2 Agilent Technologies Business Overview
11.2.3 Agilent Technologies Personalized Medicine Introduction
11.2.4 Agilent Technologies Revenue in Personalized Medicine Business (2016-2021)
11.2.5 Agilent Technologies Recent Development
11.3 Amgen
11.3.1 Amgen Company Details
11.3.2 Amgen Business Overview
11.3.3 Amgen Personalized Medicine Introduction
11.3.4 Amgen Revenue in Personalized Medicine Business (2016-2021)
11.3.5 Amgen Recent Development
11.4 Astellas Pharma
11.4.1 Astellas Pharma Company Details
11.4.2 Astellas Pharma Business Overview
11.4.3 Astellas Pharma Personalized Medicine Introduction
11.4.4 Astellas Pharma Revenue in Personalized Medicine Business (2016-2021)
11.4.5 Astellas Pharma Recent Development
11.5 Astrazeneca
11.5.1 Astrazeneca Company Details
11.5.2 Astrazeneca Business Overview
11.5.3 Astrazeneca Personalized Medicine Introduction
11.5.4 Astrazeneca Revenue in Personalized Medicine Business (2016-2021)
11.5.5 Astrazeneca Recent Development
11.6 Bayer AG
11.6.1 Bayer AG Company Details
11.6.2 Bayer AG Business Overview
11.6.3 Bayer AG Personalized Medicine Introduction
11.6.4 Bayer AG Revenue in Personalized Medicine Business (2016-2021)
11.6.5 Bayer AG Recent Development
11.7 Celgene Corporation
11.7.1 Celgene Corporation Company Details
11.7.2 Celgene Corporation Business Overview
11.7.3 Celgene Corporation Personalized Medicine Introduction
11.7.4 Celgene Corporation Revenue in Personalized Medicine Business (2016-2021)
11.7.5 Celgene Corporation Recent Development
11.8 Glaxosmithkline Plc
11.8.1 Glaxosmithkline Plc Company Details
11.8.2 Glaxosmithkline Plc Business Overview
11.8.3 Glaxosmithkline Plc Personalized Medicine Introduction
11.8.4 Glaxosmithkline Plc Revenue in Personalized Medicine Business (2016-2021)
11.8.5 Glaxosmithkline Plc Recent Development
11.9 Illumina
11.9.1 Illumina Company Details
11.9.2 Illumina Business Overview
11.9.3 Illumina Personalized Medicine Introduction
11.9.4 Illumina Revenue in Personalized Medicine Business (2016-2021)
11.9.5 Illumina Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Personalized Medicine Introduction
11.10.4 Johnson & Johnson Revenue in Personalized Medicine Business (2016-2021)
11.10.5 Johnson & Johnson Recent Development
11.11 Laboratory Corporation
11.11.1 Laboratory Corporation Company Details
11.11.2 Laboratory Corporation Business Overview
11.11.3 Laboratory Corporation Personalized Medicine Introduction
11.11.4 Laboratory Corporation Revenue in Personalized Medicine Business (2016-2021)
11.11.5 Laboratory Corporation Recent Development
11.12 Merck
11.12.1 Merck Company Details
11.12.2 Merck Business Overview
11.12.3 Merck Personalized Medicine Introduction
11.12.4 Merck Revenue in Personalized Medicine Business (2016-2021)
11.12.5 Merck Recent Development
11.13 Novartis AG
11.13.1 Novartis AG Company Details
11.13.2 Novartis AG Business Overview
11.13.3 Novartis AG Personalized Medicine Introduction
11.13.4 Novartis AG Revenue in Personalized Medicine Business (2016-2021)
11.13.5 Novartis AG Recent Development
11.14 Roche Holding AG
11.14.1 Roche Holding AG Company Details
11.14.2 Roche Holding AG Business Overview
11.14.3 Roche Holding AG Personalized Medicine Introduction
11.14.4 Roche Holding AG Revenue in Personalized Medicine Business (2016-2021)
11.14.5 Roche Holding AG Recent Development
11.15 Siemens AG
11.15.1 Siemens AG Company Details
11.15.2 Siemens AG Business Overview
11.15.3 Siemens AG Personalized Medicine Introduction
11.15.4 Siemens AG Revenue in Personalized Medicine Business (2016-2021)
11.15.5 Siemens AG Recent Development
11.16 Takeda Pharmaceutical Company Limited
11.16.1 Takeda Pharmaceutical Company Limited Company Details
11.16.2 Takeda Pharmaceutical Company Limited Business Overview
11.16.3 Takeda Pharmaceutical Company Limited Personalized Medicine Introduction
11.16.4 Takeda Pharmaceutical Company Limited Revenue in Personalized Medicine Business (2016-2021)
11.16.5 Takeda Pharmaceutical Company Limited Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Personalized Medicine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Personalized Medicine Diagnostics
Table 3. Key Players of Personalized Medical Care
Table 4. Key Players of Personalized Medicine Therapeutics
Table 5. Key Players of Personalized Nutrition and Wellness
Table 6. Global Personalized Medicine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Personalized Medicine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Personalized Medicine Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Personalized Medicine Market Share by Regions (2016-2021)
Table 10. Global Personalized Medicine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Personalized Medicine Market Share by Regions (2022-2027)
Table 12. Personalized Medicine Market Trends
Table 13. Personalized Medicine Market Drivers
Table 14. Personalized Medicine Market Challenges
Table 15. Personalized Medicine Market Restraints
Table 16. Global Personalized Medicine Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Personalized Medicine Market Share by Players (2016-2021)
Table 18. Global Top Personalized Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Personalized Medicine as of 2020)
Table 19. Ranking of Global Top Personalized Medicine Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Personalized Medicine Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Personalized Medicine Product Solution and Service
Table 23. Date of Enter into Personalized Medicine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Personalized Medicine Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Personalized Medicine Revenue Market Share by Type (2016-2021)
Table 27. Global Personalized Medicine Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Personalized Medicine Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Personalized Medicine Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Personalized Medicine Revenue Market Share by Application (2016-2021)
Table 31. Global Personalized Medicine Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Personalized Medicine Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Personalized Medicine Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Personalized Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Personalized Medicine Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Personalized Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Personalized Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Personalized Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Personalized Medicine Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Personalized Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Personalized Medicine Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Personalized Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Personalized Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Personalized Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Personalized Medicine Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Personalized Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Personalized Medicine Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Personalized Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Personalized Medicine Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Personalized Medicine Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Personalized Medicine Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Personalized Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Personalized Medicine Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Personalized Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Personalized Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Personalized Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Personalized Medicine Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Personalized Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Personalized Medicine Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Personalized Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Personalized Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Personalized Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 63. Abbott Laboratories Company Details
Table 64. Abbott Laboratories Business Overview
Table 65. Abbott Laboratories Personalized Medicine Product
Table 66. Abbott Laboratories Revenue in Personalized Medicine Business (2016-2021) & (US$ Million)
Table 67. Abbott Laboratories Recent Development
Table 68. Agilent Technologies Company Details
Table 69. Agilent Technologies Business Overview
Table 70. Agilent Technologies Personalized Medicine Product
Table 71. Agilent Technologies Revenue in Personalized Medicine Business (2016-2021) & (US$ Million)
Table 72. Agilent Technologies Recent Development
Table 73. Amgen Company Details
Table 74. Amgen Business Overview
Table 75. Amgen Personalized Medicine Product
Table 76. Amgen Revenue in Personalized Medicine Business (2016-2021) & (US$ Million)
Table 77. Amgen Recent Development
Table 78. Astellas Pharma Company Details
Table 79. Astellas Pharma Business Overview
Table 80. Astellas Pharma Personalized Medicine Product
Table 81. Astellas Pharma Revenue in Personalized Medicine Business (2016-2021) & (US$ Million)
Table 82. Astellas Pharma Recent Development
Table 83. Astrazeneca Company Details
Table 84. Astrazeneca Business Overview
Table 85. Astrazeneca Personalized Medicine Product
Table 86. Astrazeneca Revenue in Personalized Medicine Business (2016-2021) & (US$ Million)
Table 87. Astrazeneca Recent Development
Table 88. Bayer AG Company Details
Table 89. Bayer AG Business Overview
Table 90. Bayer AG Personalized Medicine Product
Table 91. Bayer AG Revenue in Personalized Medicine Business (2016-2021) & (US$ Million)
Table 92. Bayer AG Recent Development
Table 93. Celgene Corporation Company Details
Table 94. Celgene Corporation Business Overview
Table 95. Celgene Corporation Personalized Medicine Product
Table 96. Celgene Corporation Revenue in Personalized Medicine Business (2016-2021) & (US$ Million)
Table 97. Celgene Corporation Recent Development
Table 98. Glaxosmithkline Plc Company Details
Table 99. Glaxosmithkline Plc Business Overview
Table 100. Glaxosmithkline Plc Revenue in Personalized Medicine Business (2016-2021) & (US$ Million)
Table 101. Glaxosmithkline Plc Recent Development
Table 102. Illumina Company Details
Table 103. Illumina Business Overview
Table 104. Illumina Personalized Medicine Product
Table 105. Illumina Revenue in Personalized Medicine Business (2016-2021) & (US$ Million)
Table 106. Illumina Recent Development
Table 107. Johnson & Johnson Company Details
Table 108. Johnson & Johnson Business Overview
Table 109. Johnson & Johnson Personalized Medicine Product
Table 110. Johnson & Johnson Revenue in Personalized Medicine Business (2016-2021) & (US$ Million)
Table 111. Johnson & Johnson Recent Development
Table 112. Laboratory Corporation Company Details
Table 113. Laboratory Corporation Business Overview
Table 114. Laboratory Corporation Personalized Medicine Product
Table 115. Laboratory Corporation Revenue in Personalized Medicine Business (2016-2021) & (US$ Million)
Table 116. Laboratory Corporation Recent Development
Table 117. Merck Company Details
Table 118. Merck Business Overview
Table 119. Merck Personalized Medicine Product
Table 120. Merck Revenue in Personalized Medicine Business (2016-2021) & (US$ Million)
Table 121. Merck Recent Development
Table 122. Novartis AG Company Details
Table 123. Novartis AG Business Overview
Table 124. Novartis AG Personalized Medicine Product
Table 125. Novartis AG Revenue in Personalized Medicine Business (2016-2021) & (US$ Million)
Table 126. Novartis AG Recent Development
Table 127. Roche Holding AG Company Details
Table 128. Roche Holding AG Business Overview
Table 129. Roche Holding AG Personalized Medicine Product
Table 130. Roche Holding AG Revenue in Personalized Medicine Business (2016-2021) & (US$ Million)
Table 131. Roche Holding AG Recent Development
Table 132. Siemens AG Company Details
Table 133. Siemens AG Business Overview
Table 134. Siemens AG Personalized Medicine Product
Table 135. Siemens AG Revenue in Personalized Medicine Business (2016-2021) & (US$ Million)
Table 136. Siemens AG Recent Development
Table 137. Takeda Pharmaceutical Company Limited Company Details
Table 138. Takeda Pharmaceutical Company Limited Business Overview
Table 139. Takeda Pharmaceutical Company Limited Personalized Medicine Product
Table 140. Takeda Pharmaceutical Company Limited Revenue in Personalized Medicine Business (2016-2021) & (US$ Million)
Table 141. Takeda Pharmaceutical Company Limited Recent Development
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Personalized Medicine Market Share by Type: 2020 VS 2027
Figure 2. Personalized Medicine Diagnostics Features
Figure 3. Personalized Medical Care Features
Figure 4. Personalized Medicine Therapeutics Features
Figure 5. Personalized Nutrition and Wellness Features
Figure 6. Global Personalized Medicine Market Share by Application: 2020 VS 2027
Figure 7. Oncology Case Studies
Figure 8. Central Nervous System (CNS) Case Studies
Figure 9. Immunology Case Studies
Figure 10. Respiratory Case Studies
Figure 11. Other Applications Case Studies
Figure 12. Personalized Medicine Report Years Considered
Figure 13. Global Personalized Medicine Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Personalized Medicine Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Personalized Medicine Market Share by Regions: 2020 VS 2027
Figure 16. Global Personalized Medicine Market Share by Regions (2022-2027)
Figure 17. Global Personalized Medicine Market Share by Players in 2020
Figure 18. Global Top Personalized Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Personalized Medicine as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Personalized Medicine Revenue in 2020
Figure 20. Global Personalized Medicine Revenue Market Share by Type (2016-2021)
Figure 21. Global Personalized Medicine Revenue Market Share by Type (2022-2027)
Figure 22. North America Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Personalized Medicine Market Share by Type (2016-2027)
Figure 24. North America Personalized Medicine Market Share by Application (2016-2027)
Figure 25. North America Personalized Medicine Market Share by Country (2016-2027)
Figure 26. United States Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Personalized Medicine Market Share by Type (2016-2027)
Figure 30. Europe Personalized Medicine Market Share by Application (2016-2027)
Figure 31. Europe Personalized Medicine Market Share by Country (2016-2027)
Figure 32. Germany Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Personalized Medicine Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Personalized Medicine Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Personalized Medicine Market Share by Region (2016-2027)
Figure 42. China Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Personalized Medicine Market Share by Type (2016-2027)
Figure 50. Latin America Personalized Medicine Market Share by Application (2016-2027)
Figure 51. Latin America Personalized Medicine Market Share by Country (2016-2027)
Figure 52. Mexico Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Personalized Medicine Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Personalized Medicine Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Personalized Medicine Market Share by Country (2016-2027)
Figure 58. Turkey Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Abbott Laboratories Revenue Growth Rate in Personalized Medicine Business (2016-2021)
Figure 62. Agilent Technologies Revenue Growth Rate in Personalized Medicine Business (2016-2021)
Figure 63. Amgen Revenue Growth Rate in Personalized Medicine Business (2016-2021)
Figure 64. Astellas Pharma Revenue Growth Rate in Personalized Medicine Business (2016-2021)
Figure 65. Astrazeneca Revenue Growth Rate in Personalized Medicine Business (2016-2021)
Figure 66. Bayer AG Revenue Growth Rate in Personalized Medicine Business (2016-2021)
Figure 67. Celgene Corporation Revenue Growth Rate in Personalized Medicine Business (2016-2021)
Figure 68. Glaxosmithkline Plc Revenue Growth Rate in Personalized Medicine Business (2016-2021)
Figure 69. Illumina Revenue Growth Rate in Personalized Medicine Business (2016-2021)
Figure 70. Johnson & Johnson Revenue Growth Rate in Personalized Medicine Business (2016-2021)
Figure 71. Laboratory Corporation Revenue Growth Rate in Personalized Medicine Business (2016-2021)
Figure 72. Merck Revenue Growth Rate in Personalized Medicine Business (2016-2021)
Figure 73. Novartis AG Revenue Growth Rate in Personalized Medicine Business (2016-2021)
Figure 74. Roche Holding AG Revenue Growth Rate in Personalized Medicine Business (2016-2021)
Figure 75. Siemens AG Revenue Growth Rate in Personalized Medicine Business (2016-2021)
Figure 76. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Personalized Medicine Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs